News

Managing Breast Cancer-Related Symptoms


 

Paroxetine at 20 mg/day appears to be roughly as effective as venlafaxine at reducing hot flashes, based upon randomized controlled studies by other investigators. Sertraline at 50 and 100 mg/day doesn't seem to work as well as do the other antidepressants.

Tamoxifen is metabolized by cytochrome P450 2D6 to a key active metabolite, endoxifen, which is believed to be responsible for the selective estrogen receptor modulator's efficacy in preventing breast cancer. Coadministration of paroxetine and tamoxifen has been reported to result in a significant decrease in plasma endoxifen levels (J. Natl. Cancer Inst. 2003;95:1758–64). In contrast, venlafaxine didn't reduce endoxifen levels in another study (Clin. Pharmacol. Ther. 2006;80:61–74).

'Exercise is the answer, not more rest,' for patients experiencing fatigue after chemotherapy. DR. LOPRINZI

Pages

Recommended Reading

Fewer Adverse Events With Cyclic OCs After Endometrioma Excision
MDedge ObGyn
Added Calcium Raises MI Risk in Older Women
MDedge ObGyn
Switching AIs Often Effective for Joint Symptoms
MDedge ObGyn
Cranberry Products Reduce Symptomatic UTIs
MDedge ObGyn
Nonhormonal Therapy Cuts Hot Flashes in 26-Week Trial
MDedge ObGyn
Metronidazole Gel Called Best Option for Recurrent BV, for Now
MDedge ObGyn
Genital Wart Treatment Options Expanding
MDedge ObGyn
Placebo-Free OC May Improve Bleeding Pattern
MDedge ObGyn
Early Zoledronic Acid Beats Late for AI Bone Loss
MDedge ObGyn
Metformin May Have Novel Role as Breast Cancer Drug
MDedge ObGyn